HomeRB0 • FRA
add
Regenxbio Inc
Previous close
€11.30
Day range
€11.40 - €11.40
Year range
€4.68 - €11.70
Market cap
610.37M USD
Avg Volume
123.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 29.73M | 22.88% |
Operating expense | 20.32M | 4.41% |
Net income | -61.94M | -3.93% |
Net profit margin | -208.32 | 15.42% |
Earnings per share | -1.20 | -2.56% |
EBITDA | -48.52M | 16.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.20M | 7.34% |
Total assets | 525.20M | 1.17% |
Total liabilities | 363.75M | 67.09% |
Total equity | 161.45M | — |
Shares outstanding | 50.62M | — |
Price to book | 3.54 | — |
Return on assets | -23.69% | — |
Return on capital | -28.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -61.94M | -3.93% |
Cash from operations | -55.96M | -38.01% |
Cash from investing | 42.29M | -15.86% |
Cash from financing | -7.08M | 34.76% |
Net change in cash | -20.76M | -1,708.01% |
Free cash flow | -33.31M | -85.44% |
About
Founded
2008
Headquarters
Website
Employees
353
